Identifying potential tumor markers and antigens by database mining and rapid expression screening [5]

Genome Research

Volumn 10, Issue 9, 2000, Pages 1393-1402

  Loging, W Troy ^a   Lal, Anita ^a   Siu, I Mei ^a   Loney, Tania L ^a   Wikstrand, Carol J ^a   Marra, Marco A ^b   Prange, Christa ^c   Bigner, Darell D ^a   Strausberg, Robert L ^d   Riggins, Gregory J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN; TUMOR MARKER;

BRAIN TUMOR; CANCER GENETICS; COMPUTER SYSTEM; CONTROLLED STUDY; DATA BASE; DRUG TARGETING; FLUORESCENCE; GENE EXPRESSION; GENE LOCATION; GENETIC SCREENING; GLIOBLASTOMA; HUMAN; LETTER; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ALGORITHMS; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; DATABASES, FACTUAL; FLUORESCENT DYES; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMANS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033794854     PISSN: 10889051     EISSN: None     Source Type: Journal    
DOI: 10.1101/gr.138000     Document Type: Letter

References (47)

1. Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library
2. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues
3. Human liver nicotinamide N-methyltransferase: cDNA cloning, expression, and biochemical characterization
4. Dendritic cells: Development, function and potential use for cancer immunotherapy
5. Development of dendritic cells and their use in tumor therapy
6. Quantitative RT-PCR: Pitfalls and potential developments in quantitative PCR
7. Immunotherapy of cancer with dendritic-cell-based vaccines
8. The Sec61 complex is located in both the ER and the ER-Golgi intermediate compartment
9. Hybridization fingerprinting of high-density cDNA-library arrays with cDNA pools derived from whole tissues
10. Evaluation of HER-2/neu (erbB-2) status in breast cancer: From bench to bedside
11. Expression of the genes encoding bombesin-related peptides and their receptors in anterior pituitary tissue
12. Regulation of angiogenesis by SPARC and angiostatin: Implications for tumor cell biology
13. Tumour serum markers: Clinical and economical aspects
14. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)
15. Primary and secondary glioblastomas: From concept to clinical diagnosis
16. Tissue microarrays for high-throughput molecular profiling of tumor specimens
17. MRP3, an organic anion transporter able to transport anti-cancer drugs
18. Enhanced expression of lipocortin-1 as a new immunosuppressive protein in cancer patients and its influence on reduced in vitro peripheral blood lymphocyte response to mitogens
19. Molecular cloning of cDNAs encoding the human bombesin-like peptide neuromedin B. Chromosomal localization and comparison to cDNAs encoding its amphibian homolog ranatensin
20. A public database for gene expression in human cancers
21. The biology of SPARC, a protein that modulates cell-matrix interactions
22. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells
23. Expression monitoring by hybridization to high-density oligonucleotide arrays
24. Tumor-associated hyaluronic acid: A new sensitive and specific urine marker for bladder cancer
25. Microsatellite alterations as clonal markers for the detection of human cancer
26. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma
27. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification
28. Novel therapeutic strategies to selectively kill cancer cells
29. Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma
30. SPARC: A potential diagnostic marker of invasive meningiomas
31. SPARC: A signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas
32. Study of natural lipocortin. I. A potent mediator for macrophage-mediated immunosuppression in tumor-bearing mice
33. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
34. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors
35. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer
36. Laser-capture microdissection: Opening the microscopic frontier to molecular analysis
37. New opportunities for uncovering the molecular basis of cancer
38. Analysis of human transcriptomes
39. Serial analysis of gene expression
40. Digital PCR
41. Prediction of gene function by genome-scale expression analysis: Prostate cancer-associated genes
42. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity
43. nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts
44. Continuous fluorescence monitoring of rapid cycle DNA amplification
45. Review of circulating tumor markers: From enzyme, carcinoembryonic protein to oncogene and suppressor gene
46. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents